Keywords: تومور ناهمگونی; Head and neck cancer; Clonal evolution; TP53; PIK3CA; MLL2; Tumour heterogeneity; Subclonal selection;
مقالات ISI تومور ناهمگونی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تومور ناهمگونی; Osteosarcoma; Bone cancer; Cancer stem cell; Tumour heterogeneity;
Keywords: تومور ناهمگونی; Cancer stem cells; Chemotherapy; De-differentiation; Metastasis; Tumour heterogeneity; Tumour cell plasticity;
Keywords: تومور ناهمگونی; NGS technology; Target genes; Tumour heterogeneity; Genetic complexity; Personalised medicine; HNSCC;
Keywords: تومور ناهمگونی; Ovarian cancer; Relapse; Platinum-free interval; Platinum-sensitive recurrence; Partially platinum-sensitive recurrence; Tumour heterogeneity
Keywords: تومور ناهمگونی; Melanoma; Therapy resistance; Tumour heterogeneity; Tumour plasticity
PD-L1 expression predicts longer disease free survival in high risk head and neck cutaneous squamous cell carcinoma
Keywords: تومور ناهمگونی; Skin cancer; squamous cell carcinoma; immunohistochemistry; PD-L1; PD-1; tumour biomarkers; tumour microenvironment; tumour heterogeneity; disease-free survival;
Advances in understanding tumour evolution through single-cell sequencing*
Keywords: تومور ناهمگونی; Single-cell sequencing; Cancer evolution; Tumour heterogeneity; Phylogenetics;
Genetic variants in the HER2 gene: Influence on HER2 overexpression and loss of heterozygosity in breast cancer
Keywords: تومور ناهمگونی; Breast cancer; HER2; Pharmacogenomics; Tumour heterogeneity;
Original articleTechnical innovation in adjuvant radiotherapy: Evolution and evaluation of new treatments for today and tomorrow
Keywords: تومور ناهمگونی; Radiotherapy; Partial breast irradiation; Radiosensitivity; Tumour heterogeneity; Tumour microenvironment;
The evolving cancer stem cell paradigm: Implications in veterinary oncology
Keywords: تومور ناهمگونی; Cancer stem cells; Tumour heterogeneity; Cellular reprogramming; Cancer cell plasticity; Stemness; Lineage tracing;
Intratumour Heterogeneity in Urologic Cancers: From Molecular Evidence to Clinical Implications
Keywords: تومور ناهمگونی; Biomarker; Bladder cancer; Cancer evolution; Genetics; Personalised medicine; Prostate cancer; Renal cancer; Tumour heterogeneity;
Anti-cancer drug resistance: Understanding the mechanisms through the use of integrative genomics and functional RNA interference
Keywords: تومور ناهمگونی; Drug resistance; RNA interference; Chromosomal instability; Genome instability; Tumour heterogeneity; Integrative genomics; Next generation sequencing; Targeted therapy; Biomarker discovery
Tumour heterogeneity and the assessment of expression of proteins for targeted biological therapies
Keywords: تومور ناهمگونی; cancer; cetuximab; immunohistochemistry; trastuzumab; tumour heterogeneity;
Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: Relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease
Keywords: تومور ناهمگونی; Breast cancer; Progenitor cells; Tumour subtypes; Tumour heterogeneity; Proteomics; CK15IHC, immunohistochemistry; 2D PAGE, two-dimensional polyacrylamide gel electrophoresis